NovaBay Pharmaceuticals I... (NBY)
0.59
-0.02 (-2.48%)
At close: Mar 03, 2025, 12:10 PM
NovaBay Pharmaceuticals Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 |
| Net Income | -9.64M | -10.61M | -5.82M | -11.04M | -9.66M | -6.54M | -7.4M | -13.15M | -18.97M | -15.19M | -16.04M | -7.03M | -5.08M | -4.31M | 2.7M | -8.11M | -5.4M | -5.29M | -3.46M |
| Depreciation & Amortization | 203K | 483K | 119K | 51K | 65K | 266K | 95K | 114K | 164K | 232K | 314K | 341K | 425K | 427K | 373K | 304K | 183K | 74K | 48K |
| Stock-Based Compensation | 291K | 220K | 1.15M | 701K | 621K | 594K | 2.04M | 1.75M | 1.38M | 1.04M | 1.02M | 1.54M | 1.22M | 1.4M | 1.28M | 983K | 428K | n/a | n/a |
| Other Working Capital | 134K | 388K | -84K | 322K | -41K | -138K | -205K | 115K | 413K | 691K | -366K | 46K | 11.72M | -3.25M | 34K | -3.35M | -1.84M | 9.6M | 102K |
| Other Non-Cash Items | 4.26M | 2.72M | -4.62M | 89K | 688K | -1.23M | 605K | 2.31M | -2.15M | -1.68M | 1.18M | -1.13M | 732K | 3.26M | 8K | -23K | 392K | 356K | 83K |
| Deferred Income Tax | n/a | n/a | n/a | 5.27M | -849K | n/a | n/a | n/a | n/a | n/a | -442K | n/a | 37K | n/a | 34K | -35K | -428K | n/a | n/a |
| Change in Working Capital | 750K | 533K | -38K | 210K | 1.2M | 1.35M | -1.6M | -3.16M | 1.02M | 543K | 999K | -252K | -472K | 1.25M | -6.04M | -3.06M | -1.45M | 9.6M | 102K |
| Operating Cash Flow | -4.13M | -6.65M | -9.19M | -4.72M | -7.93M | -5.57M | -6.27M | -12.13M | -18.56M | -15.05M | -12.97M | -6.53M | -3.14M | 2.03M | -1.65M | -9.94M | -6.27M | 4.74M | -3.23M |
| Capital Expenditures | -19K | -112K | -52K | -26K | -19K | -44K | -244K | -160K | -123K | -68K | -141K | -148K | -119K | -203K | -731K | -610K | -663K | -362K | -123K |
| Acquisitions | n/a | n/a | -11.99M | n/a | n/a | n/a | n/a | n/a | 37K | n/a | 21K | n/a | 25K | n/a | n/a | -35K | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.01M | -4.33M | -4.87M | -7.58M | -2.45M | -3.98M | -32.1M | -49.2M | -11.29M | -1.96M |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.55M | 5.88M | 6.38M | 3.04M | 1.46M | 3.63M | 43.57M | 44.2M | 6.14M | 936K |
| Other Investing Acitivies | n/a | n/a | -11.99M | n/a | n/a | n/a | n/a | n/a | 37K | 128K | -21K | 6K | -25K | n/a | 2K | 35K | 1K | 1K | 1K |
| Investing Cash Flow | -19K | -112K | -12.04M | -26K | -19K | -44K | -244K | -160K | -86K | 2.6M | 1.41M | 1.36M | -4.67M | -1.19M | -1.07M | 10.86M | -5.66M | -5.51M | -1.14M |
| Debt Repayment | 1.53M | -105K | 105K | n/a | 2.35M | n/a | n/a | -1.66M | 1.66M | n/a | n/a | -71K | -35K | -371K | -408K | 83K | -31K | n/a | -20K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | -48K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 384K | 4.74M | 31.59M | 4.54M | 2.66M | 12K | 201K | 7.43M | 2.43M | 7.16M | 3.25M | 6.74M | 4.74M | -2K | 74K | 153K | 716K | -93K | 873K |
| Financial Cash Flow | 1.91M | 4.63M | 16.79M | 9.76M | 11.7M | 5.6M | 201K | 19.42M | 15.6M | 7.39M | 9.33M | 9.47M | 4.7M | -292K | 1.61M | 236K | 17.97M | 3.46M | 2.53M |
| Net Cash Flow | -2.24M | -2.13M | -4.45M | 5.01M | 3.75M | -15K | -6.31M | 7.13M | -3.04M | -5.07M | -2.23M | 4.31M | -3.11M | 542K | -1.11M | 1.16M | 6.04M | 2.69M | -1.84M |
| Free Cash Flow | -4.15M | -6.77M | -9.24M | -4.75M | -7.95M | -5.61M | -6.51M | -12.29M | -18.68M | -15.12M | -13.11M | -6.68M | -3.26M | 1.82M | -2.38M | -10.55M | -6.93M | 4.38M | -3.35M |